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SUMMARY
Methylergometrine is probably the most commonly used drug in obstetric care at 
all levels of the health care system. Many communities in Africa lack skilled birth 
attendants and adequate health systems; medication errors are more likely to occur 
and go unreported in these settings. The morbidity and mortality that result from 
these errors can be reduced if health care workers are better informed. We report two 
cases of medication error with methylergometrine and suggest guidelines for health 
care workers at the primary and secondary levels of health care.
INTRODUCTION
Errors in the administration of drugs occur commonly 
and are a leading cause of mortality and morbidity (1). 
The true incidence in developing countries especially 
in sub-Saharan Africa is unknown. Most errors cause 
no harm, but the administration of the wrong dose or 
the wrong drug may have life threatening effects.
 Methylergometrine, a semi-synthetic derivative 
of the amine-alkaloid group of ergot compounds 
has uterotonic and vasoconstrictive effects that has 
been widely used in the prevention of postpartum 
haemorrhage since the 1950s (2). It is usually kept in 
labour rooms for immediate parenteral use during 
the last stage of labour.
 A limited number of cases of ergot poisoning in 
the newborn have been reported worldwide (3-5). Most 
cases resulted from confusion of methyergometrine 
with vitamin K or naloxone. Affected newborns 
present with respiratory depression, encephalopathy, 
seizures and disturbances in the peripheral 
circulation. Death is usually caused by respiratory 
failure. We report two cases of methylergometrine 
poisoning referred to the neonatal intensive care unit 
of Korle Bu Teaching Hospital, Accra, Ghana.
CASE REPORTS
Case 1: A 3.3 kilogram, full term female infant was 
born by spontaneous vaginal delivery (SVD) after an 
uncomplicated pregnancy. The Apgar scores were 
6 and 8 at one and five minutes respectively; she 
required oropharyngeal suctioning and facial oxygen 
for resuscitation at birth. Soon after birth a nurse 
assistant administered 1ml of methylergometrine 
(0.5 mg of ergometrine maleate) intramuscularly, 
believing it to be vitamin K. The error was recognised 
immediately, but the nurses were not sure of what 
to do; hence intramuscular hydrocortisone was 
administered. Within 30 minutes the infant became 
cyanosed, with shallow breaths and had an apneic 
event. She was referred to the neonatal intensive 
care unit (NICU) within an hour after the incident 
on account of respiratory distress. The nurse who 
brought the infant confided to a NICU staff that 
methylergometrine was inadvertently given to the 
infant, but vitamin K was not given.
 The respiratory effort was shallow at 23 breaths 
per minute, heart rate 162 beats per minute, and blood 
pressure 61/34 mmHg (mean 42 mmHg). She had a 
weak cry, absent  moro reflex, and normal sucking 
reflex. Her breathing improved with bag and mask 
ventilation. Vitamin K was given. At three hours the 
infant had frequent episodes of hypoxia requiring 
intermittent bag and mask ventilation. At six hours, 
persistent hypoventilation necessitated endotracheal 
intubation and mechanical ventilation. At eight 
hours blood pressure was 68/47 mmHg (mean 60 
mmHg); sodium nitroprusside (SNP) infusion was 
commenced, with the infusion rate titrated according 
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to blood pressure control. She first passed urine at 
nine hours after birth, and urine output remained 
normal thereafter.
 She had no clinical seizures. Blood culture was 
negative. Antibiotics were administered for five 
days. The infant was ventilated for 28 hours and 
SNP was stopped after 57 hours. A complete blood 
count on admission was normal. Renal function was 
slightly deranged on day three (Na+ 132 mmol/L, 
K+ 4.2 mmol/L, Urea 8.4 mmol/L, and creatinine 
83 μmol/L) but normalised before discharge. 
Neurological examination was normal on day three 
and she was breastfeeding on day four. The infant 
was discharged home on day eight. Outpatient 
follow-up at six weeks showed no abnormality. 
Case 2: A full term infant weighing 3.6 kilogram was 
referred to NICU at the age of 30 minutes after a 
normal SVD with persistent cyanosis. The referring 
nurse confided to a NICU nurse about inadvertent 
administration of ergometrine at birth by a student 
nurse. The infant was cyanosed, but had no other 
abnormal findings on physical examination. Vitamin 
K was given. He was admitted for observation 
and supplemental oxygen was administered. He 
had a generalised seizure at the age of two hours. 
Phenobarbitone 20mg/kg was administered. He 
subsequently had another suspected convulsion on 
day one and none thereafter. His blood pressure, 
urine output, blood electrolytes, urea and creatinine 
remained normal. Supplemental oxygen was 
discontinued on day three, and breast feeding was 
commenced. He was discharged on day seven. 
Follow-up at three months showed no neurological 
abnormality. The infant has not reported for 
subsequent follow-up.
DISCUSSION
Our patients presented with respiratory depression 
and seizures; similar clinical manifestations as 
documented by other workers. Both patients survived. 
Death from ergometrine poisoning has been reported 
(6), but majority of newborns treated in tertiary health 
facilities survive with normal neurological function 
(7).  Many affected newborns in Africa may not be 
referred to tertiary health facilities.
 The α-adrenergic effect of ergometrine, its direct 
constrictive effect on vascular smooth muscle and the 
associated loss of central control of vasomotor tone 
lead to most of the clinical manifestations of ergot 
poisoning (8). The ventilation perfusion mismatch 
resulting from pulmonary vasoconstriction may 
explain the respiratory signs in reported cases. The 
marked cyanosis is believed to result from profound 
venoconstriction. The vasoconstrictive effects on 
mesenteric and renal vasculature lead to acute end-
organ circulatory compromise. The neurological 
effects result from vasoconstriction and the direct 
effect of ergometrine on cortical neurons (9).
 There was no documentation of inadvertent 
ergometrine administration in the referral letters of 
these two cases; the nurses who brought the infants 
did not confide to the admitting doctor but to another 
NICU staff they knew personally. Other workers have 
shown that when these errors are recognised they are 
not usually documented or reported because of fear 
of disciplinary action (10).
 Prevention of this potentially life-threatening 
medication error is possible by: (a) Avoidance of 
vitamin K administration to the newborn in the first 
few minutes of life when skilled health care workers 
(HCW) are busy with the mother. (b) Keeping vitamin 
K and naloxone in separate clearly labeled areas away 
from methylergometrine. (c) Use of oral vitamin K. (d) 
Cross-checking all medication with another member 
of staff before administering it to patients.
 The poor outcome of medication errors may 
be reduced by early recognition and appropriate 
intervention with antidotes or supportive care. We 
recommend that the following steps be taken as soon as 
the inadvertent administration of methylergometrine 
in the newborn is recognised. 
(i) Vitamin K, the drug intended for the newborn 
should be administered.
(ii) The baby should be nursed in oxygen, if available, 
while urgent plans are made to transfer the infant 
to a tertiary centre as the onset of symptoms may 
be as long as three hours.
(iii) If the expertise to insert an intravenous line is 
available at the health facility; this should be 
done as soon as possible as vascular access may 
be difficult later. However, this procedure must 
not delay transfer.
(iv) Seizures should be treated promptly with 
phenobarbitone 20mg/kg.
(v) A senior member of staff should counsel the 
parents and the health worker who administered 
the medication as this event causes significant 
emotional trauma to both. 
Many HCW in Africa lack knowledge about the drugs 
they administer to patients and the consequences 
of medication error there-of. As a result most 
medication errors may be unrecognised and therefore 
unreported; downplaying the event when recognised 
or inappropriately management as in Case 1 is more 
likely. These actions delay or prevent appropriate 
referral and management of affected patients thus 
increasing morbidity or mortality.
 Less punitive system-centred approach to 
improve drug administration safety has been shown 
(11) to increase reporting of drug errors by HCW. Such 
approach coupled with continuing medical education 
of HCW on drug administration safety may reduce 
morbidity and mortality from medication errors in 
Africa. 
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